共 160 条
[1]
Younossi ZM(2016)Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes Hepatology 64 73-84
[2]
Koenig AB(2020)Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States Clin Gastroenterol Hepatol 30 2119-2121
[3]
Abdelatif D(2007)Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients Diabetes Care 367 1-1350
[4]
Fazel Y(2019)Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults BMJ 363 1341-1402
[5]
Henry L(2010)Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease N Engl J Med 64 1388-2061
[6]
Wymer M(2016)EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease J Hepatol 120 2053-S6
[7]
Younossi ZM(2009)Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease Circulation 4 S1-e126
[8]
Stepanova M(2002)Classification, epidemiology, risk factors, and natural history of peripheral arterial disease Diabetes Obes Metab 69 e71-743
[9]
Ong J(2017)2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines J Am Coll Cardiol 110 738-1325
[10]
Trimble G(2004)Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000 Circulation 6 33-2041